Sea You at Fetch Long Beach
|Articles|July 1, 2006

Bayer introduces IV joint therapy

Shawnee Mission, Kan. - Bayer Animal Health introduces Legend? (hyaluronate sodium), an FDA-approved intravenous equine joint therapy.

SHAWNEE MISSION, KAN. — Bayer Animal Health introduces Legend® (hyaluronate sodium), an FDA-approved intravenous equine joint therapy.

Legend Multi Dose's 20-mL vial is equivalent to five doses, making it easier and more convenient to transport, the company says.

Legend helps stop acute joint damage before it becomes chronic.

Hyaluronic acid (HA) is a normal component of joint fluid and cartilage and serves many functions, one of which is to act as a lubricant to the soft-tissue structures of the joint and decrease inflammation. Legend is pure HA, the same polysaccharide present in normal joint fluid.

Legend Multi Dose contains benzyl alcohol as a preservative and can only be given intravenously. The intravenous administration does not require joint preparation, benefits multiple joint sites and saves administration time.

Legend is not to be used in horses intended for food.

For fastest response, call

(800) 255-6517

www.bayerdvm.com


Related to this article

Laverdia now available for purchase for dogs with lymphoma
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option that is given twice weekly and showed a longer time to disease progression than control in a field study.
Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.